<DOC>
	<DOCNO>NCT01565005</DOCNO>
	<brief_summary>The purpose study : I . Compare neuroradiological phenotype cognitive function MCPH patient cause ASPM mutation already characterize publish ( Passemard et al . 2009a ) MCPH-related patient ( patient MCPH1 , WDR62 , CDK5RAP2 , CEP 152 , CENPJ , STIL , PCNT mutation ) II . Describe neuro-radiological cognitive phenotype microcephalic patient suffer Fanconi anemia , compare subject : - Fanconi anemia normal OFC ( head circumference ) - MCPH patient - Healthy control subject Our hypothesis mutation gene responsible microcephaly impact differentially cortical brain development functioning</brief_summary>
	<brief_title>Microcephaly Genetic Deficiency Neural Progenitors</brief_title>
	<detailed_description>Phenotyping study 2 different cohort rare disease affect patient : - Group1 : MCPH ( include different MCPH subtypes ) - Group2 : Fanconi Anemia ( without microcephaly ) Inclusion criterion : Common group : - Age &gt; 3 year - Access french `` Social Security '' - No contraindication MRI Group1 : - Primary microcephaly without gross malformation within extra nervous central system - OFC &lt; -2SD birth &lt; -3 SD age 6months - Mutation one MCPH gene Group2 : Proven Fanconi Anemia : - Positive chromosome breakage blood test - One 3 follow element : FANCD2 positive test Fibroblast sensitivity mitomycin Mutation one FANC gene Control subject : - No antecedent - Normal education Aims : 1 . Description neurological , neuropsychological radiological phenotype group 2 . Phenotype comparison : - group 1 &amp; 2 - group1 2 control subject - different MCPH subtypes within group1 - without microcephaly within group2 3 . Epidemiological data rare disease population Protocol : Patients group control subject evaluate CIC 1 day ½ . They examine child neurologist geneticist . All cranial MRI ( 1.5Tesla ) . Neuropsychological assessment perform ( Wechsler scale ) patient control subject .</detailed_description>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Microcephaly</mesh_term>
	<criteria>Patients age ≥ 3 year : Microcephalic phenotype consistent MCPH ( recruitment already do part network GISRare Diseases Institute ) . MCPH patient already select cohort `` Robert Debré . '' Holders Fanconi anemia characterize term cytogenetics , enzyme and/or molecular ( patient cohort `` Saint Louis '' follow KRC rare aplastic anemia ) Healthy control age ≥ 5 year siblings patient Fanconi Anemia Patients Fanconi anemia : bone marrow &lt; 3 year Posttransplantation neurological complication developmental , genetic environmental additional pathology</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>MCPH</keyword>
	<keyword>FANCONI ANEMIA</keyword>
</DOC>